Tagged with Canada

Alzheimer’s Immunotherapies: Are We There Yet?
Biosimilar Policies in Canada: To Switch or Not to Switch?
New GSK flu vaccine deal, Amylyx Pharmaceuticals’ ALS approval and Chimerix and Bavarian Nordic smallpox contracts
Innovators Applaud Canada’s Decision NOT to Proceed with Excessive Price Factor Amendments
Top 10 Global Pharma Markets Ranking
CADTH CEO Suzanne McGurn on the Key Challenges in HTA Today
Concrete Steps Toward National Pharmacare in Canada
Top 10 Pharma Companies in Canada Ranking 2020
Canada: Federal Consultations on a National Strategy for Rare Disease Drugs
The bright future of mRNA technology – InConversation Podcast #Episode1:  w/Thomas D. Madden, Founder,  Acuitas Therapeutics
Thomas D. Madden – CEO, Acuitas Therapeutics
Canada’s COVID-19 Vaccination Strategy
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here